Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Clinical Oncology

• Publication date

  2004-08-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2004.10.012PMID 15310771
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Peritoneal carcinomatosis of colorectal cancer: incidence, prognosis, and treatment modalities

  2004cited by this paper
• Surgery combined with peritonectomy procedures and intraperitoneal chemohyperthermia in abdominal cancers with peritoneal carcinomatosis: a phase II study.

  2003cited by this paper
• New Perspectives in the Management of Colorectal Cancer: What about Peritoneal Carcinomatosis?

  2003cited by this paper
• Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.

  2003influential reference
• [Endocrine therapy of causation: role of aromatase inhibitors in breast cancer].

  2003cited by this paper
• Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Intraoperative Chemotherapy for Peritoneal Carcinomatosis Arising From Colon Adenocarcinoma

  2003cited by this paper
• Intraperitoneal Chemohyperthermia Using a Closed Abdominal Procedure and Cytoreductive Surgery for the Treatment of Peritoneal Carcinomatosis: Morbidity and Mortality Analysis of 216 Consecutive Procedures

  2003cited by this paper
• Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis.

  2003cited by this paper
• Treatment and prevention of peritoneal carcinomatosis from colorectal cancer.

  2003cited by this paper
• Carcinomatosis--is cure an option?

  2003cited by this paper
• [Indications for integrated surgical treatment of peritoneal carcinomatosis of colorectal origin: experience of the Italian Society of Locoregional Integrated Therapy in Oncology].

  2003cited by this paper
• Peritoneal carcinomatosis from colorectal cancer

  2002cited by this paper
• Cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma or pleural metastases of thymoma.

  2002cited by this paper
• Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin.

  2001cited by this paper
• Surgical Debulking and Intraperitoneal Chemotherapy for Established Peritoneal Metastases From Colon and Appendix Cancer

  2001cited by this paper
• Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy

  2001cited by this paper
• Intraperitoneal chemohyperthermia: rationale, technique, indications, and results.

  2001cited by this paper
• Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis

  2000cited by this paper
• Treatment of primary colon cancer with peritoneal carcinomatosis

  2000cited by this paper
• Peritoneal carcinomatosis from non‐gynecologic malignancies

  2000cited by this paper
• Intraperitoneal chemohyperthermia for peritoneal carcinomatosis: original modeling, clinical tolerance and results study about 30 patients.

  2000cited by this paper
• Sem : un outil de gestion informatique et statistique adapté à la recherche en cancérologie

  2000cited by this paper
• Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial.

  2000cited by this paper
• Treatment of peritoneal carcinomatosis with intent to cure

  2000cited by this paper
• [Sem: a suitable statistical software adaptated for research in oncology].

  2000cited by this paper
• Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra‐abdominal cancer

  2000cited by this paper
• Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.

  2000cited by this paper
• Morbidity and Mortality Analysis of 200 Treatments With Cytoreductive Surgery and Hyperthermic Intraoperative Intraperitoneal Chemotherapy Using the Coliseum Technique

  1999cited by this paper
• Chemohyperthermic peritoneal perfusion for peritoneal dissemination in various intra-abdominal malignancies.

  1999cited by this paper
• Peritonectomy combined with intraperitoneal chemohyperthermia in abdominal cancer with peritoneal carcinomatosis: phase I-II study.

  1999cited by this paper
• Colorectal cancer.

  1999cited by this paper
• A comprehensive review of 5‐fluorouracil and leucovorin in patients with metastatic colorectal carcinoma

  1997cited by this paper
• Improved survival with preoperative radiotherapy in resectable rectal cancer.

  1997cited by this paper
• Chemotherapy for the Treatment of Patients with Metastatic Colorectal Cancer: An Overview

  1997cited by this paper
• Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis.

  1996cited by this paper
• Prognostic Features of 51 Colorectal and 130 Appendiceal Cancer Patients with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy

  1995cited by this paper
• Peritonectomy procedures.

  1995cited by this paper
• Colorectal cancer

  1993cited by this paper
• Peritoneal seeding following potentially curative resection of colonic carcinoma: Implications for adjuvant therapy

  1991cited by this paper
• Peritioneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors

  1989cited by this paper
• Resection of the liver for colorectal carcinoma metastases

  1988cited by this paper
• Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Registry of Hepatic Metastases.

  1988cited by this paper
• Adenocarcinoma of the sigmoid colon: Sites of initial dissemination and clinical patterns of recurrence following surgery alone

  1983cited by this paper
• Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cells.

  1981cited by this paper
• Regression Models and Life-Tables

  1972cited by this paper
• The effects of heat and radiation on cancers implanted on the feet of mice.

  1963cited by this paper
• Statistical aspects of the analysis of data from retrospective studies of disease.

  1959cited by this paper

• Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Outcomes for Colorectal and Mesothelioma Peritoneal Metastases: A 12-year Study

  2026cites this paper
• Mitomycin C-Based Hyperthermic Intraperitoneal Chemotherapy Improves Survival in Colorectal Cancer With Peritoneal Metastasis

  2026cites this paper
• Risk factors for postoperative acute kidney injury after cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: a meta-analysis and systematic review

  2025cites this paper
• Current status of postoperative morbidity following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer with peritoneal metastasis: a prospective single-center observational study

  2025cites this paper
• Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for children and young adults: experience from two high volume centers

  2025cites this paper
• Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases Offers 60% Five-Year Overall Survival for Low-Volume Disease

  2025cites this paper
• Combined retroperitoneal resection with cytoreductive surgery and heated intraperitoneal chemotherapy for metastatic colorectal cancer with retroperitoneal and peritoneal metastases.

  2025cites this paper
• Repeat Diagnostic Laparoscopy After Chemotherapy is Useful in Patient Selection for Conversion to Cytoreductive Surgery for Initially Unresectable Colorectal and Appendiceal Peritoneal Metastases: A Retrospective Cohort Study

  2025cites this paper
• Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC) and Liver-Directed Therapy for Synchronous Peritoneal and Liver Metastatic Colorectal Cancer: A Systematic Review with Meta-analysis

  2025cites this paper
• Advancing Treatment Outcomes for Peritoneal Surface Malignancies in Low- and Middle-Income Countries: Insights from the First Multicenter Study in North Africa

  2025cites this paper
• Executive Summary of the American Radium Society Appropriate Use Criteria for the Management of Peritoneal Carcinomatosis From Different Tumor Origins: Systematic Review and Guidelines

  2025cites this paper
• Diagnostic Advances and Novel Therapeutics in Peritoneal Metastasis.

  2025cites this paper
• The epidemiology, current evidence and controversies in diagnosis and management of patients with colorectal peritoneal metastases.

  2025cites this paper
• The impact of laparoscopic vs open primary colon resection on long-term outcomes after subsequent cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for metachronous peritoneal metastasis

  2025cites this paper
• Radiological Advances In CRS-HIPEC Planning for Peritoneal Carcinomatosis: A Meta-Analysis Of MRI, CT, PET-CT, And Clinical Outcomes

  2025cites this paper
• Management and Outcomes of Urinary Tract Involvement in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC): A Retrospective Cohort Study

  2025cites this paper
• Prophylactic Intraperitoneal Chemotherapy with Platinum Agents Following Curative Resection for Colorectal Cancer: A Systematic Review and Meta-Analysis.

  2025cites this paper
• Worse Survival in Co-Altered RAS-TP53 Patients With Resected Colorectal Liver Metastases

  2025cites this paper
• Trends in Colorectal Cancer Peritoneal Metastases Research: A Comprehensive Bibliometric Analysis

  2025cites this paper
• Challenges in setting up the first cyto-reductive surgery (CRS) and hyperthermic intra-peritoneal chemotherapy (HIPEC) service in Malaysia.

  2025cites this paper
• Cytoreductive Surgery (CS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Postoperative Evolution, Adverse Outcomes and Perioperative Risk Factors

  2025cites this paper
• An Increasing Role for Cytoreductive Surgery in Metastatic Colorectal Cancer—National Trends in the Era of More Effective Systemic Therapy

  2025cites this paper
• Repeat Cytoreductive Surgery for Colorectal Cancer Metastatic to the Peritoneal Cavity

  2025cites this paper
• Great Debate: Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases—Should It Be Offered?

  2025cites this paper
• Treatment and Outcomes of Peritoneal Surface Malignancies by Cytoreductive Surgery (CRS) And Hyperthermic Intraperitoneal Chemotherapy (HIPEC) In A Tier-3 City in India: A Report from A Tertiary Cancer Centre

  2025cites this paper
• Evaluating long-term outcomes after cytoreductive surgery for colorectal peritoneal metastasis: do long survivors really exist?

  2025cites this paper
• ASO Authors Reflections: Beyond the Boundaries of Colorectal Cancer Peritoneal and Liver Metastases: Insights from a Systematic Review

  2025cites this paper
• Peritoneal Cancer Index Dominates Prognosis After CRS–HIPEC for Colorectal Peritoneal Metastases: A Consecutive Single-Centre Cohort with 3-Year Follow-Up

  2025cites this paper
• Efficacy and safety of subtotal pelvic peritonectomy for colorectal cancer patients with peritoneal metastasis confined to the pelvic cavity.

  2025cites this paper
• Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy outcomes in peritoneal carcinomatosis: 11-year tertiary-center experience

  2025cites this paper
• Incidence, risk factors, and outcomes of the transition of HIPEC-induced acute kidney injury to acute kidney disease: a retrospective study

  2024cites this paper
• Repeat cytoreduction with Hyperthermic Intraperitoneal chemotherapy in patients with peritoneal disease: A 5-year retrospective analysis.

  2024cites this paper
• Systemic Chemotherapy in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery: Systematic Review and Meta-Analysis

  2024cites this paper
• Fabrication of poly (lactic-co-glycolic acid)/mesoporous silica composite nanofibers for controllable co-delivery of 5-fluorouracil and curcumin against HT-29 colon cancer cells

  2024cites this paper
• Long‐term outcomes and survival analysis of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei at a newly established peritoneal malignancy centre in Japan

  2024cites this paper
• Repeat cytoreductive surgery with HIPEC for colorectal peritoneal metastases: a systematic review

  2024cites this paper
• Metastatic Colorectal Cancer Treated with Combined Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Predictive Factors for Early Recurrence

  2024cites this paper
• Follow-up for More than 10 Years of Patients with Peritoneal Metastases Treated with Cytoreductive Surgery + Hyperthermic Intraperitoneal Chemotherapy in a Specialized Unit

  2024cites this paper
• Critical reappraisal of prognostic indicators for 949 mucinous appendiceal neoplasm patients

  2024cites this paper
• Extremely high peritoneal cancer index in colorectal peritoneal metastases demonstrates safety and overall survival benefit in selected patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy.

  2024cites this paper
• Current Status of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer (CRC)

  2024cites this paper
• Survival Analysis and Recurrence Patterns in 555 Patients with Colorectal Peritoneal Metastases Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

  2024influential citation
• Prospects of the Surgical Management of Colorectal Peritoneal Metastasis.

  2024cites this paper
• INDEPSO-ISPSM Consensus on Peritoneal Malignancies: Management of Colorectal Peritoneal Metastases

  2024cites this paper
• Prognostic Value of Immune Scoring System for Colorectal Cancer Patients with Peritoneal Metastasis

  2024cites this paper
• Total parietal peritonectomy and multivisceral resection for extensive cytoreductive surgery in pseudomyxoma peritonei: En bloc "Rolled-up carpet" technique and perioperative and oncologic outcomes.

  2024cites this paper
• Cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy applications in upper and lower gastrointestinal cancer, a review

  2024cites this paper
• Surgical and survival outcomes of cytoreductive surgery alone or with perioperative intraperitoneal chemotherapy in high peritoneal cancer index.

  2024cites this paper
• Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy and Liver Resection is a Treatment Option for Patients With Peritoneal and Liver Metastases From Colorectal Cancer

  2024cites this paper
• The Importance of Preoperative NLR, PLR, and MPV Values in Predicting the Risk of Complications in Colorectal Peritoneal Carcinomatosis

  2024cites this paper
• The history of cytoreduction and HIPEC: Heating up or just blowing smoke?

  2024cites this paper
• Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is NOT a Last Resort: Rationale for Early Surgical Referral.

  2024cites this paper
• Inflammatory Bowel Disease in Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy

  2024cites this paper
• A pan-cancer dye for solid-tumour screening, resection and wound monitoring via short-wave and near-infrared fluorescence imaging

  2024cites this paper
• Cytoreductive surgery without intra-peritoneal chemotherapy for metachronous colorectal peritoneal metastases

  2024cites this paper
• Effectiveness of hyperthermic intraperitoneal chemotherapy during primary curative resection for colorectal carcinoma

  2024cites this paper
• [Contribution of intraperitoneal chemotherapy in the treatment of colorectal peritoneal carcinoma. HIPEC, PIPAC, state of the art and future directions].

  2024cites this paper
• A pan-cancer agent for screening, resection and wound monitoring via NIR and SWIR imaging

  2024cites this paper
• Is Hyperthermic Intraperitoneal Chemotherapy Appropriate for Colon Cancer?

  2024cites this paper
• Role of Locoregional Therapy in Gastric Cancer with Peritoneal Metastasis

  2024cites this paper
• Should Cytoreductive Surgery Alone for Peritoneal Metastases of Colorectal Origin be Centralized? A National Study of 4159 Procedures

  2024cites this paper
• Morbidity and mortality of patients with peritoneal malignancy following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

  2024cites this paper
• Predictors of major postoperative complications in cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy

  2024cites this paper
• Efficacy and safety of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with pancreatic cancer peritoneal metastasis

  2024cites this paper
• Advances in the Treatment of Colorectal Cancer with Peritoneal Metastases: A Focus on Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

  2023cites this paper
• Optimizing Treatment Strategy for Oligometastases/Oligo-Recurrence of Colorectal Cancer

  2023cites this paper
• Biopsychosocial Late Effects After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases from Colorectal and Appendiceal Cancer: A National Prospective Cohort Study

  2023cites this paper
• The influence of postoperative morbidity on medium to long-term quality of life trajectories following cytoreductive surgery for peritoneal malignancy– A prospective cohort study

  2023cites this paper
• The Role of Prophylactic and Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Prevention of Peritoneal Metastases in Advanced Colorectal Cancer

  2023cites this paper
• Peritoneal Metastasis: A Dilemma and Challenge in the Treatment of Metastatic Colorectal Cancer

  2023cites this paper
• Perioperative and Oncological Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastasis of Rectal Origin

  2023cites this paper
• Treatment and prognosis of colorectal cancer with synchronous peritoneal metastases: 11-year single institute experience

  2023cites this paper
• KICO: Surgeon-Centered Collaborative Tool to Aid Peritoneal Carcinomatosis Assessment

  2023cites this paper
• Is Systemic Chemotherapy Useful in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Colorectal Peritoneal Metastases? A Propensity-Score Analysis

  2023cites this paper
• External validation of prognostic scores and comparison of predictive accuracy for patients with colorectal cancer with peritoneal metastases considered for cytoreductive surgery and intraperitoneal chemotherapy

  2023cites this paper
• Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still beneficial in patients diagnosed with colorectal peritoneal metastasis who underwent palliative chemotherapy?

  2023cites this paper
• Cytoreductive surgery for synchronous and metachronous colorectal peritoneal dissemination: Japanese P classification and peritoneal cancer index

  2023cites this paper
• Deep epigastric lymph nodes implication in patients' recurrence pattern after cytoreductive surgery in ovarian peritoneal metastases.

  2023cites this paper
• Investigation of the effectiveness of hyperthermic intraperitoneal chemotherapy in experimental colorectal peritoneal metastasis model

  2023cites this paper
• Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treatment of peritoneal metastasis.

  2023influential citation
• Secondary Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy for Advanced or Recurrent Mucinous Ovarian Cancer

  2023cites this paper
• Comparison of Cytoreductive Surgery and Resection of Isolated Peritoneal Metastases in Patients with Peritoneal Metastases from Colorectal Cancer: A Retrospective Study

  2023cites this paper
• Recommendations for the optimal management of peritoneal metastases in patients with colorectal cancer: a TTD and GECOP-SEOQ expert consensus statement

  2023cites this paper
• Use of Prognostic Factors and Scores in Selection of Patients with Colorectal Cancer Peritoneal Metastasis (CRPM) for Cytoreductive Surgery and Intraperitoneal Chemotherapy (CRS/IPC): Results of an International Survey Among Oncologic Clinicians

  2023cites this paper
• Meeting actual benchmarks for short- and long-term outcomes after cytoreductive surgery for peritoneal surface malignancy at a newly established academic treatment center.

  2023cites this paper
• Delaying Surgery After Neoadjuvant Chemotherapy Affects Survival in Patients with Colorectal Peritoneal Metastases: A BIG-RENAPE Network Multicentric Study

  2023cites this paper
• Predicting peritoneal recurrence in gastric cancer with serosal invasion using a pathomics nomogram

  2023cites this paper
• Role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Colorectal Peritoneal Metastases

  2023cites this paper
• Clinical and Histopathologic Features of 35 Patients Treated for Colorectal Peritoneal Metastases Who Survived 5 Years

  2023cites this paper
• Survival improvement for patients with metastatic colorectal cancer over twenty years

  2023cites this paper
• Incomplete cytoreductive surgery for appendiceal and colorectal peritoneal carcinomatosis: Characteristics and outcomes of an overlooked group

  2023cites this paper
• Survival benefits with EPIC in addition to HIPEC for low grade appendiceal neoplasms with pseudomyxoma peritonei: a propensity score matched study

  2023cites this paper
• Activated Leukocyte Cell Adhesion Molecule (ALCAM), a Potential ‘Seed’ and ‘Soil’ Receptor in the Peritoneal Metastasis of Gastrointestinal Cancers

  2023cites this paper
• Surgical Options for Peritoneal Surface Metastases from Digestive Malignancies—A Comprehensive Review

  2023cites this paper
• A novel risk model for predicting peritoneal metastasis in colorectal cancer based on the SEER database

  2023cites this paper
• Current Research and Development in Hyperthermic Intraperitoneal Chemotherapy (HIPEC)—A Cross-Sectional Analysis of Clinical Trials Registered on ClinicalTrials.gov

  2023cites this paper
• Survival Outcomes of Optimally Treated Colorectal Metastases: The Importance of R0 Status in Surgical Treatment of Hepatic and Peritoneal Surface Disease

  2023cites this paper
• Outcomes of preoperative chemotherapy for colorectal cancer with peritoneal metastasis underwent cytoreductive surgery

  2023cites this paper
• Perioperative chemotherapy in colorectal cancer with peritoneal metastases: A global propensity score matched study

  2022cites this paper
• Evaluating the concept of gas‑based intraperitoneal hyperthermia beyond 43˚C in the treatment of peritoneal metastasis: A pilot study

  2022cites this paper